Glutathione reduced (GSH) may be a potential biomarker or etiologic factor in women 18 months postpartum at moderate to high risk of suicide, according to a team of Brazilian researchers.
The Brazilian Health Regulatory Agency (ANVISA) has approved Kyowa Hakko’s Setria ingredient, making it the first glutathione authorized for use in dietary supplements and functional foods in the country.